Tsuyoshi Nishiguchi, MD PhD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    In-Kind Research Support
    Ineligible company: 
    Sumitomo Pharma
    Topic: 
    Research funding
    Date added: 
    05/04/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    04/30/2024
    Date reviewed: 
    06/02/2023
Return to 0042_ADS_13th Annual Conference of the American Delirium Society_Live